Powered by

-AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson's Disease Diagnostic Imaging Agent

Sep 05, 2019 - ENP Newswire

LAUSANNE - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded a new grant for the Company's pioneering alpha-synuclein (a-syn) positron-emission tomography (PET) tracer program.

Over the last four years, AC Immune has received continuous grant support from MJFF to accelerate development of a-syn PET t...